68 reports of this reaction
8.7% of all BARIUM SULFATE reports
#1 most reported adverse reaction
ASPIRATION is the #1 most commonly reported adverse reaction for BARIUM SULFATE, manufactured by E-Z-EM Canada Inc. There are 68 FDA adverse event reports linking BARIUM SULFATE to ASPIRATION. This represents approximately 8.7% of all 781 adverse event reports for this drug.
Patients taking BARIUM SULFATE who experience aspiration should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ASPIRATION is moderately reported among BARIUM SULFATE users, representing a notable but not dominant share of adverse events.
In addition to aspiration, the following adverse reactions have been reported for BARIUM SULFATE:
The following drugs have also been linked to aspiration in FDA adverse event reports:
ASPIRATION has been reported as an adverse event in 68 FDA reports for BARIUM SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ASPIRATION accounts for approximately 8.7% of all adverse event reports for BARIUM SULFATE, making it one of the most commonly reported side effect.
If you experience aspiration while taking BARIUM SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.